Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CEL-SCI to develop Covid-19 immunotherapy

pharmaceutical-technologyMarch 12, 2020

Tag: immunotherapy , COVID-19 , CEL-SCI

PharmaSources Customer Service